These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29334787)

  • 1. Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients.
    Espejo-Porras F; Fernández-Ruiz J; de Lago E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):377-386. PubMed ID: 29334787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of CB
    Fernández-Trapero M; Espejo-Porras F; Rodríguez-Cueto C; Coates JR; Pérez-Díaz C; de Lago E; Fernández-Ruiz J
    Dis Model Mech; 2017 May; 10(5):551-558. PubMed ID: 28069688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the CB
    Rodríguez-Cueto C; Gómez-Almería M; García Toscano L; Romero J; Hillard CJ; de Lago E; Fernández-Ruiz J
    Brain Pathol; 2021 Nov; 31(6):e12972. PubMed ID: 33983653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glial cannabinoid CB
    Espejo-Porras F; García-Toscano L; Rodríguez-Cueto C; Santos-García I; de Lago E; Fernandez-Ruiz J
    Br J Pharmacol; 2019 May; 176(10):1585-1600. PubMed ID: 29574689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders.
    Espejo-Porras F; Piscitelli F; Verde R; Ramos JA; Di Marzo V; de Lago E; Fernández-Ruiz J
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):233-44. PubMed ID: 25819934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
    Moreno-Martet M; Espejo-Porras F; Fernández-Ruiz J; de Lago E
    CNS Neurosci Ther; 2014 Sep; 20(9):809-15. PubMed ID: 24703394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.
    Fujita K; Yamauchi M; Matsui T; Titani K; Takahashi H; Kato T; Isomura G; Ando M; Nagata Y
    Brain Res; 1998 Feb; 785(1):31-40. PubMed ID: 9526038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.
    Yiangou Y; Facer P; Durrenberger P; Chessell IP; Naylor A; Bountra C; Banati RR; Anand P
    BMC Neurol; 2006 Mar; 6():12. PubMed ID: 16512913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis.
    Sarlette A; Krampfl K; Grothe C; Neuhoff Nv; Dengler R; Petri S
    J Neuropathol Exp Neurol; 2008 Nov; 67(11):1055-62. PubMed ID: 18957896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-NMDA receptors in motor neuron disease (MND): a quantitative autoradiographic study in spinal cord and motor cortex using [3H]CNQX and [3H]kainate.
    Shaw PJ; Chinnery RM; Ince PG
    Brain Res; 1994 Aug; 655(1-2):186-94. PubMed ID: 7812772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases.
    Moreno-Martet M; Mestre L; Loría F; Guaza C; Fernández-Ruiz J; de Lago E
    Neurosci Lett; 2012 Feb; 508(2):67-72. PubMed ID: 22206832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
    Benito C; Romero JP; Tolón RM; Clemente D; Docagne F; Hillard CJ; Guaza C; Romero J
    J Neurosci; 2007 Feb; 27(9):2396-402. PubMed ID: 17329437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias.
    Rodríguez-Cueto C; Benito C; Romero J; Hernández-Gálvez M; Gómez-Ruiz M; Fernández-Ruiz J
    Pathobiology; 2014; 81(3):149-59. PubMed ID: 24642775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis.
    Jokic N; Ling YY; Ward RE; Michael-Titus AT; Priestley JV; Malaspina A
    J Neurochem; 2007 Dec; 103(5):1821-33. PubMed ID: 17956549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of secreted phosphoprotein 1 (osteopontin) in human sensorimotor cortex and spinal cord: Changes in patients with amyotrophic lateral sclerosis.
    Yamamoto T; Murayama S; Takao M; Isa T; Higo N
    Brain Res; 2017 Jan; 1655():168-175. PubMed ID: 27823929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
    Burgaz S; García C; Gonzalo-Consuegra C; Gómez-Almería M; Ruiz-Pino F; Unciti JD; Gómez-Cañas M; Alcalde J; Morales P; Jagerovic N; Rodríguez-Cueto C; de Lago E; Muñoz E; Fernández-Ruiz J
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H; Weber E; Korhonen L; Lindholm D
    Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study.
    Fray AE; Ince PG; Banner SJ; Milton ID; Usher PA; Cookson MR; Shaw PJ
    Eur J Neurosci; 1998 Aug; 10(8):2481-9. PubMed ID: 9767379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.